40
https://pubmed.ncbi.nlm.nih.gov/38091429
New and emerging therapies, such as immune checkpoint inhibitors and targeted therapies, as well as novel approaches like nanotechnology, are being explored to improve treatment outcomes for metastatic melanoma, with a focus on overcoming resistance and the lack of predictive biomarkers.
